Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments ...

A breast cancer drug paired with venetoclax significantly enhanced leukemia cell killing and durability in preclinical tests.

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

The German government has sharply rejected claims by U.S. Health Secretary Robert F. Kennedy Jr. that it sidelined patient ...

Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.

NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with ...

Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...

Scientists are literally turning back the clocks in our cells, with the first drugs about to go to human trials ...